Tags

Type your tag names separated by a space and hit enter

Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress.
Endocrine. 2013 Apr; 43(2):360-9.E

Abstract

Bone marrow mesenchymal stem cells (BMSCs) are potential therapy for diabetes. Owing to the oxidative stress caused by hyperglycemia, these transplanted BMSCs are with high rate of apoptotic death after transplantation. Ginkgo biloba L. extract (EGB) is a potent antioxidant which can remove free radicals. The study was to investigate whether EGB can protect BMSCs from oxidative stress in vitro and enhance the efficacy of BMSCs in lowering blood glucose levels after transplantation. BMSCs were cultured with H2O2, EGB, or H2O2 and EGB. Cell viability, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and cell death rates were determined. Diabetes was induced by single injection of streptozotocin (STZ) in male Wistar rats. Diabetic rats received EGB, BMSCs, or EGB/BMSCs. The serum levels of glucose, insulin, interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), MDA, SOD, and GSH-Px were determined. PKCα expression and NF-κB activation in kidney were determined. The MDA levels and cell death rates in BMSCs cultured with H2O2 and EGB were significantly lower; cell viability, SOD, and GSH-Px activities were significantly higher compared with those with H2O2 alone. Compared with diabetic rats receiving BMSCs, diabetic rats receiving EGB before BMSCs transplantation showed (1) significantly lower levels of blood glucose, serum MDA, IL-6, and TNF-α, and higher levels of insulin, SOD, and GSH-Px activities; (2) significantly lower PKCα expression and NF-κB activation in the kidney. EGB administration before BMSC transplantation can enhance the effectiveness of BMSCs in lowering blood glucose levels and reversing oxidative stress in diabetic rats.

Authors+Show Affiliations

Department of Toxicology, School of Public Health, Jilin University, 1163 Xinmin Street, Changchun, 130021, Jilin, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22815043

Citation

Ren, Ming, et al. "Ginkgo Biloba L. Extract Enhances the Effectiveness of Syngeneic Bone Marrow Mesenchymal Stem Cells in Lowering Blood Glucose Levels and Reversing Oxidative Stress." Endocrine, vol. 43, no. 2, 2013, pp. 360-9.
Ren M, Yang S, Li J, et al. Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. Endocrine. 2013;43(2):360-9.
Ren, M., Yang, S., Li, J., Hu, Y., Ren, Z., & Ren, S. (2013). Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. Endocrine, 43(2), 360-9. https://doi.org/10.1007/s12020-012-9745-5
Ren M, et al. Ginkgo Biloba L. Extract Enhances the Effectiveness of Syngeneic Bone Marrow Mesenchymal Stem Cells in Lowering Blood Glucose Levels and Reversing Oxidative Stress. Endocrine. 2013;43(2):360-9. PubMed PMID: 22815043.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. AU - Ren,Ming, AU - Yang,Shujuan, AU - Li,Jianhui, AU - Hu,Yulin, AU - Ren,Zhixing, AU - Ren,Shuping, Y1 - 2012/07/20/ PY - 2012/05/21/received PY - 2012/07/05/accepted PY - 2012/7/21/entrez PY - 2012/7/21/pubmed PY - 2013/9/26/medline SP - 360 EP - 9 JF - Endocrine JO - Endocrine VL - 43 IS - 2 N2 - Bone marrow mesenchymal stem cells (BMSCs) are potential therapy for diabetes. Owing to the oxidative stress caused by hyperglycemia, these transplanted BMSCs are with high rate of apoptotic death after transplantation. Ginkgo biloba L. extract (EGB) is a potent antioxidant which can remove free radicals. The study was to investigate whether EGB can protect BMSCs from oxidative stress in vitro and enhance the efficacy of BMSCs in lowering blood glucose levels after transplantation. BMSCs were cultured with H2O2, EGB, or H2O2 and EGB. Cell viability, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and cell death rates were determined. Diabetes was induced by single injection of streptozotocin (STZ) in male Wistar rats. Diabetic rats received EGB, BMSCs, or EGB/BMSCs. The serum levels of glucose, insulin, interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), MDA, SOD, and GSH-Px were determined. PKCα expression and NF-κB activation in kidney were determined. The MDA levels and cell death rates in BMSCs cultured with H2O2 and EGB were significantly lower; cell viability, SOD, and GSH-Px activities were significantly higher compared with those with H2O2 alone. Compared with diabetic rats receiving BMSCs, diabetic rats receiving EGB before BMSCs transplantation showed (1) significantly lower levels of blood glucose, serum MDA, IL-6, and TNF-α, and higher levels of insulin, SOD, and GSH-Px activities; (2) significantly lower PKCα expression and NF-κB activation in the kidney. EGB administration before BMSC transplantation can enhance the effectiveness of BMSCs in lowering blood glucose levels and reversing oxidative stress in diabetic rats. SN - 1559-0100 UR - https://www.unboundmedicine.com/medline/citation/22815043/Ginkgo_biloba_L__extract_enhances_the_effectiveness_of_syngeneic_bone_marrow_mesenchymal_stem_cells_in_lowering_blood_glucose_levels_and_reversing_oxidative_stress_ L2 - https://dx.doi.org/10.1007/s12020-012-9745-5 DB - PRIME DP - Unbound Medicine ER -